Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and ...

Among 347,468 individuals who had lived with persistent pain for over 3 months, clinical symptoms of depression and anxiety ...

Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...

Major depressive disorder with seasonal patterns, also known as seasonal affective disorder, causes symptoms similar to ...

Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...

A large-scale study published in Molecular Psychiatry has uncovered a distinct pattern of biological changes in people with ...

J&J is discontinuing the Phase 3 test of its drug, aticaprant, in major depressive disorder “due to insufficient efficacy in the target patient population,” the company said after Thursday’s ...

Menopause can worsen symptoms of bipolar disorder. In rare cases, it may trigger bipolar disorder. Menopause is a factor when ...

Mind Medicine ($MNMD) announced its Q4 financials and indicated it is making strides in developing innovative treatments for ...

Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...